Catalyst Wire Dossier Catalyst Wire Dossier

OBIZUR

recombinant porcine factor VIII (rpFVIII) · Takeda
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OBIZUR, covering 2025-08-12 to 2025-11-21. Get the full timeline:

Most recent: EMA Authorised: Obizur (susoctocog alfa) — Baxalta Innovations GmbH

See pricing